Home/ Products / Full-length Membrane Proteins
DMF1022-50ug
50 ug
$1,800
DMF1022-100ug
100 ug
$2,400
| gene name | CLDN18 |
| alias | SFTA5, SFTPJ, Claudin 18.2 |
| gene id | Uniprot ID: P56856 |
| host species | Human |
| production host | HEK293 |
| formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose was added as protectants before lyophilization. |
| reconstitution | Reconstitute lyophilized powder with water to a concentration of no less than 100 ug/ml, solubilize at RT for 30 min with occasional gentle mixing. It is recommended that 0.1% of HSA be added as a carrier protein for long term storage. |
| shipping | Shipped at ambient conditions. |
| storage | Lyophilized form is stable for 1 week at room temperature. Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, store at 4°C for 2-7 days or at below -20°C for up to 3 months. |
ELISA plates were pre-coated with 0.5ug/well purified human CLDN18.2 VLP. Serial diluted anti-CLDN18.2 monoclonal antibody (Zolbetuximab biosililar; IMAB362) solutions were added, washed, and incubated with secondary antibody before ELISA reading. Calculated from the data, EC50 for IMAB362 binding with CLDN18.2 VLP is 15.37ng/ml.
FACS analysis of CLDN18.2 VLP. A. Negative Control 1: CLDN18.2 VLP were stained only with Goat anti-human IgG Fc-PE secondary antibody. B. Negative Control 2: Control VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1ug/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. C. Negative Control 3: CLDN18.2 VLP were stained with anti-BCMA antibody (an irrelevant antibody) at 1ug/mL, followed by Goat anti-human IgG Fc-PE secondary antibody. D. CLDN18.2 VLP were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar; IMAB362) at 1ug/mL, followed by Goat anti-human IgG Fc-PE secondary antibody.
DMF1022-50ug
50 ug
$1,800
DMF1022-100ug
100 ug
$2,400